Faeth Therapeutics FTH
$7.88 −$0.81 (-9.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.88 0.00%
Open$8.52
Prev close$8.69
Day range$7.84 – $9.13
Volume419.1K
Market cap$203.65M
P/E (TTM)–
Dividend yield–
FTH Stock News
Headlines matching Faeth Therapeutics or the FTH ticker, most recent first.
- TD Cowen Initiates Faeth Therapeutics(FTH.US) With Buy Rating
- H.C. Wainwright Maintains Faeth Therapeutics(FTH.US) With Buy Rating, Maintains Target Price $60
- Guggenheim Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $70
- BTIG Maintains Faeth Therapeutics(FTH.US) With Buy Rating, Maintains Target Price $55
- Lucid Capital Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $59
- Oppenheimer Maintains Faeth Therapeutics(FTH.US) With Buy Rating, Maintains Target Price $60
- JonesTrading Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $55
- Needham Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $56
- Raymond James Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $56
- Oppenheimer Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $60
- Citizens JMP Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $51
- Citi Maintains Faeth Therapeutics(FTH.US) With Buy Rating, Maintains Target Price $55
- Baird Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $57
- H.C. Wainwright Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $60
- BTIG Maintains Faeth Therapeutics(FTH.US) With Buy Rating, Maintains Target Price $55
No comments yet — be the first to weigh in on FTH.
Sign in to join the discussion.